IP Library Granted Patent US 9,433,501
Granted Patent B2
US 9,433,501 · App. 13/110,812 · Granted Sep 6, 2016

Inflation media for implants

Inventors: Aruna Perera (Santa Rosa, CA); Trevor Greenan (Santa Rosa, CA); Larry Rogers (San Rafael, CA)
Assignee: DIRECT FLOW MEDICAL, INC.
A61F2/2439A61F2/2418A61F2/2436C08G59/5026C08L63/00A61F2210/0085A61F2220/0008A61F2220/0016A61F2250/0003A61M25/005A61M25/0009A61M25/0023A61M25/0054A61M2025/0046A61M2025/0681B29C47/0028B29L2031/7542G01N2203/0071G01N2203/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,433,501
App. No.
13/110,812
Granted
Sep 6, 2016
Kind
B2
Abstract

An inflatable implant is disclosed. The inflatable implant comprises at least one inflation channel for forming an inflatable structure of the inflatable implant; and an inflation media disposed within the at least one inflation channel, wherein the inflation media comprises a mixture of an epoxy resin and a hardener, the mixture is configured to gel at about 37° C in less than about 2.5 hours after mixing to form a gelled mixture.

Claims (18)

1. An inflation media comprising:

an epoxy resin comprising a first compound having at least one N,N-bis(oxiran-2-ylmethyl)aniline segment and a second compound having at least two oxirane groups on a backbone of no more than five carbons;

a hardener comprising at least one cycloaliphatic amine; and

wherein a mixture of the epoxy resin and the hardener has an average viscosity of less than about 100 cps at about 37° C. over the first 10 minutes of formation; and

wherein the first compound is about 40% to about 60% by weight and the second compound is about 40% to about 60% by weight of the epoxy resin.

2. The inflation media of claim 1 , wherein the first compound is N,N-diglycidyl-4-glycidyloxyaniline or 4,4′-methylenebis(N,N-diglycidylaniline).

3. The inflation media of claim 1 , wherein the second compound is selected from the group consisting of 1,4-butanediol diglycidyl ether, 1,2-ethanediol diglycidyl ether, polyglycidyl ether, and 1,3-butadiene diepoxide.

4. The inflation media of claim 1 , wherein the at least one cycloaliphatic amine is selected from the group consisting of isophorone diamine, 1,3-bis-aminocyclohexane, diamino cyclohexane, n-aminoethylpiperazine, and n-aminopropylpiperazine.

5. The inflation media of claim 1 , wherein the hardener comprises isophorone diamine and 1,3-bis-aminocyclohexane.

6. The inflation media of claim 1 , wherein the first compound is N,N-diglycidyl-4-glycidyloxyaniline, the second compound is 1,4-butanediol diglycidyl ether, and the hardener comprises isophorone diamine and 1,3-bis-aminocyclohexane.

7. The inflation media of claim 1 , wherein the epoxy resin further comprises a third compound having at least one of the following group:

8. The inflation media of claim 7 , wherein the third compound is selected from the group consisting of tris(4-hydroxyphenyl)methane triglycidyl ether, bisphenol-A diglycidyl ether, bisphenol-F diglycidyl ether and resorcinol diglycidyl ether.

9. The inflation media of claim 1 , wherein the hardener further comprises an aliphatic amine selected from the group consisting of diethylene triamine, tri-ethylene tetraamine and tetraethylenepentamine.

10. The inflation media of claim 9 , wherein the cycloaliphatic amine is about 75% to about 100% and the aliphatic amine is about 0% to about 25% by weight of the hardener.

11. The inflation media of claim 1 , wherein the hardener further comprises a radio-opaque compound.

12. The inflation media of claim 11 , wherein the radio-opaque compound is selected from the group consisting of 3,5-diiodosalicylic acid, 3-iodo-1-propanol, 2,3,5-triiodobenzoic acid, 3,5-diiodobenzoic acid, 4-iodophenol, 2,4,6-triiodophenol, iodo benzoic acid, iodo salicylic acid, iodobenzene and diiodobenzene.

13. The inflation media of claim 1 , wherein the hardener further comprises a catalyst.

14. The inflation media of claim 13 , where in the catalyst is water, polybenzoic acid or polyphenol.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE DFM, LLC NAME IN UPLOADED DOCUMENT PREVIOUSLY RECORDED ON REEL 051882 FRAME 0125. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 25, 2020
From: DFM, LLC
To: SPEYSIDE MEDICAL LLC
Reel/Frame 052019/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2020
From: DFM, LLC
To: SPEYSIDE MEDICAL LLC
Reel/Frame 051882/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2017
From: DIRECT FLOW MEDICAL, INC.
To: DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 041080/0644 →
TRANSFER STATEMENT PURSUANT TO SECTION 9-619 OF THE UNIFORM COMMERCIAL CODE Recorded Jan 25, 2017
From: DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: DFM, LLC
Reel/Frame 041483/0220 →
SECURITY AGREEMENT Recorded Nov 5, 2013
From: DIRECT FLOW MEDICAL, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 031583/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2011
From: PERERA, ARUNA; GREENAN, TREVOR; ROGERS, LARRY
To: DIRECT FLOW MEDICAL, INC.
Reel/Frame 027062/0347 →
Continuity (2)
Provisional Application 61346419 · May 19, 2010
Related Publication 20120022629A1 · Jan 26, 2012